Company
9amHealth
No comparable monthly price verified. Dated notes below explain advertised amounts, billing periods and remaining uncertainty.
Published by Treatment Registry · Latest research
- 6 programs
- 4 identified molecules
- 6 readings
Read from join9am.com; latest program check October 2026. Individual programs and sources may have earlier verification dates.
Go to 9amHealth
Visit 9amHealth
We earn nothing from this link. It opens 9amHealth's website without a paid referral.
Terms
- Pharmacy
Not disclosed
Across recorded programs · Evidence: October 2026
- Membership
Not disclosed
Across recorded programs · Evidence: October 2026
- Consultation fee
Not disclosed
Across recorded programs · Evidence: October 2026
- States
Not disclosed
Across recorded programs · Evidence: October 2026
Programs
More columns to the right? Scroll across the table to see all details.
| Entry | Program | Form | Recorded price with its payment basis | Link |
|---|---|---|---|---|
| EntryTR-1117 | ProgramBrand semaglutide | FormNot recorded | Recorded priceNo comparable monthly price | Record |
| EntryTR-1118 | ProgramBrand tirzepatide | FormInjection, pen | Recorded priceNo comparable monthly price | Record |
| EntryTR-1119 | ProgramBrand tirzepatide | FormInjection, vial | Recorded priceNo comparable monthly price | Record |
| EntryTR-1120 | ProgramBrand tirzepatide | FormNot recorded | Recorded priceNo comparable monthly price | Record |
| EntryTR-1121 | ProgramBrand liraglutide | FormNot recorded | Recorded priceNo comparable monthly price | Record |
| EntryTR-1122 | ProgramDulaglutide | FormNot recorded | Recorded priceNo comparable monthly price | Record |
Notes
Pricing details, service terms and questions to confirm before enrolling.
October 2026
- 1. 9amHealth provides individual and benefit-sponsored cardiometabolic care through 9amHealth Medical Group of California, PC and affiliates. Prescribing depends on clinical assessment and coverage; a website listing is not a guaranteed prescription. https://join9am.com/for-individuals https://join9am.com/telehealth-consent
- 2. The current weight-management catalog names Wegovy; the separate diabetes catalog names Ozempic and Rybelsus with a confirmed type 2 diabetes requirement. Their selected presentation is not established by the current prescribing catalog. This single unknown-form category records those named alternatives; it does not assert they have the same route or are interchangeable. https://join9am.com/for-individuals https://join9am.com/lilly-diabetes
Show 8 more notesHide 8 more notes
- 3. Care and pharmacy costs are separate. The live older Wegovy campaign still shows a first-month medication offer ending June 2025, while its care cards and FAQ disagree about membership charges. None establishes a current payable total. Current terms also allow certain insurance-covered clinical services without a subscription, excluding subscription extras. Confirm the applicable care charge, pharmacy bill and lab cost before enrollment. https://join9am.com/weight-loss-wegovy https://join9am.com/terms-of-service
- 4. Prescriptions may go to a preferred or insurance-linked mail-order pharmacy; no individual dispensing pharmacy is assigned in the public catalog. The reviewed pages do not establish a medication-specific state roster. Consent allows both asynchronous communications and live audio/video care. https://join9am.com/for-individuals https://join9am.com/lilly-diabetes https://join9am.com/telehealth-consent
- 5. The current terms refer to a Shipping, Fulfillment, & Refunds Policy without exposing that policy in the captured links. The public cancellation help article could not be read because it returned an access restriction. A reliable cancellation deadline or refund entitlement was not established; confirm these terms before paying. https://join9am.com/terms-of-service https://help.9am.health/hc/en-us/articles/4415328668443-How-do-I-cancel-my-9amHealth-subscription
- 6. The current weight-management FAQ explicitly offers Zepbound Autoinjector and Zepbound Vials when prescribed. This record covers only the autoinjector. It does not transfer this device or obesity eligibility to Mounjaro. https://join9am.com/for-individuals https://join9am.com/lilly-diabetes
- 7. The current weight-management FAQ explicitly offers Zepbound Autoinjector and Zepbound Vials when prescribed. This record covers only the vial. It does not transfer this device or obesity eligibility to Mounjaro. https://join9am.com/for-individuals https://join9am.com/lilly-diabetes
- 8. The current diabetes catalog specifically names Mounjaro and requires confirmed type 2 diabetes for that pathway. Its selected device is not stated. The separate Zepbound autoinjector/vial choices do not establish a Mounjaro presentation. https://join9am.com/for-individuals https://join9am.com/lilly-diabetes
- 9. The weight-management eligibility answer names Saxenda; the current diabetes catalog names Victoza. These brand alternatives have different clinical eligibility, and the public prescribing catalog does not establish the selected device. No brand-specific pharmacy price or dose is assigned. https://join9am.com/for-individuals https://join9am.com/lilly-diabetes
- 10. The current diabetes catalog explicitly names Trulicity (dulaglutide) and requires confirmed type 2 diabetes for this pathway. No dosage form or device is specified in that current catalog. This is a diabetes-care option, not a claim of an approved weight-loss indication. https://join9am.com/for-individuals https://join9am.com/lilly-diabetes
Before you act
Cite this
Treatment Registry. (2026). 9amHealth: recorded programs and prices. Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/9am-health